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Growth ofnormal diploid mammalian cells in vitro is strongly regulated bythe actual cell density. Cell-
cell contacts via specific plasma membrane glycoproteins whose glycan moieties interact with specific
receptors has been found to be a main growth regulatory principle. Malignant growth is suggested to
result from impaired function ofthese receptors.
Density-Dependent Regulation of
Growth
The growth of nontransformed diploid mammalian
cells in vitro is characterized by a cell-density-depen-
dent regulation mechanism: with increasing cell densi-
ties, growthisreduced, leadingto astop ofproliferation
at saturation density. Several hypotheses have been
proposed to explain this density-dependent inhibition of
growth, such as the release ofinhibitory compounds by
the cells themselves (1-7), the influence of cell shape
on growth (8), the emergence ofdiffusion boundary lay-
ersinconfluentcultures, andtheexhaustion ofnutrients
orgrowth factors oftheculture medium(9). Inaddition,
specific cell-celi contacts via plasma membrane proteins
have been shown to be of major importance in the
growth regulation of normal cells (10-17).
Contact-Dependent Inhibition of
Growth
Theregulation ofgrowth by specific cell-cell contacts,
which is referred to as contact-dependent inhibition of
growth, has been studied by the addition of glutaral-
dehyde-fixed cells or isolated plasma membranes to
sparsely seeded cells (18-20). This approach led to a
concentration-dependent inhibition ofproliferationrate.
While in most ofthe cases only rudimentary data about
the molecular properties of the inhibitory compounds
havebeenprovided, some groups haveshowntheglycan
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moieties of the plasma membrane glycoproteins to be
the active part (10-12,17). Interestingly, in 3T3 fibro-
blasts, a switch from inactive molecules in sparse cells
to inhibitory compounds in confluent cultures has been
described (11). This switch resulted from the presence
of terminal N-acetylglucosamine residues on protein-
bound glycans in the case of sparse cells, while the
plasma membrane proteins from confluent cultures
were free of terminal N-acetylglucosamine. A similar
phenomenon has been described in human fibroblasts
(21); here, the inactivity of plasma membrane glyco-
proteins from sparse cells was due to the masking of
terminal galactose residues by sialic acid. Terminal
galactose residues have been shown to be essential for
the contact-dependent inhibition of growth of human
fibroblasts (22). Anotherreport described theinhibition
of growth by glycopeptides obtained after pronase
treatment ofisolated plasmamembranes (12). We were
able to show that this is also true for human fibroblasts
(20), although an inhibition ofgrowth was found only if
the glycopeptides were added in immobilized form.
Characterization of Contactibin
Immobilization on to derivatized silicabeads (23) was
a conditio-sine qua non for an effective inhibition of
growth by contactibin, the plasma membrane glycopro-
tein isolated from human fibroblasts that is responsible
for the contact-dependent inhibition of growth (manu-
script submitted). Although in immobilized form the
glycoprotein was active at picomolar concentrations
(10-50 ng/mL), even at concentrations of up to 1 ,ug/
mL, the glycoprotein had only marginal growth inhib-
itory activity when added in soluble form. The immo-
bilization may have several effects that are responsible
forthe observed inhibition ofgrowth. On one hand, thisWIESER ET AL.
method ensures that only contact-dependent phenom-
ena are induced. On the other hand, the immobilization
obviously leads to local concentrations of contactibin,
which are necessary for a biological effect. It is well
known from cell adhesion studies, for example, to im-
mobilized sugars (24), that threshold concentrations ex-
ist which provide a none-or-all reaction with respect to
adhesion. In addition, it has been shown that multi-
merization of univalent, inactive ligands leads to the
generation of highly active compounds.
Contactibin has been found to be a 60 to 70 kDa gly-
coprotein with 20 to 30% glycans, as judged from the
running behavior in SDS-PAGE. Based on immunolog-
ical studies with anti-contactibin antibodies, contactibin
is located in a detergent-extractable form in the plasma
membrane, although to a certain extent it is anchored
to cytoskeletal elements. In this form, contactibin is
resistent to detergent extraction. The conditions that
regulate the expression of contactibin in a free and
bound form are not known, but cytoskeletal binding is
suggested to have important functions forthe biological
activity on the basis of the observations with the pro-
liferation test system.
The addition of anti-contactibin antibodies to con-
fluent cultures of human normal fibroblasts resulted in
a release from contact-dependent inhibition ofgrowth.
Treated cultures showed a 2- to 3-fold higher saturation
density and the appearance of focal growth as well as
criss-cross growth pattern. Removing contactibin from
detergent extracts of isolated plasma membranes by
matrix-bound anti-contactibin antibodies resulted in a
complete lossoftheinhibitoryactivity ofthese extracts,
indicating that contactibin is the only glycoprotein in-
volved in the contact-dependent inhibition ofgrowth.
It has been found that confluent cultures of human
fibroblasts can be stimulated to go through a round of
cell division by the addition of high serum concentra-
tions or of certain growth factor combinations (EGF,
FGF, and transferrin) or ofurea (0.35 M) (unpublished
observations). In all cases a release of contactibin into
the culture medium has been observed. This may sug-
gest a causal connection and give an indication of the
necessity of the (proteolytic?) release of contactibin to
allow proliferation in confluent cultures.
Transformation has been shown to be connected with
a loss of responsiveness toward cell-cell contacts with
respecttogrowthcontrol. Thislossisnotduetochanges
ofcontactibin, as transformed cells have been found to
synthesize contactibin in biologically active form. This
is true forchemically transformed C3H 1OT1/2 cells and
for human fibrosarcoma cells (19). On the other hand,
it has been found that human tumors (sarcomas as well
as carcinomas) express various forms ofcontactibin. Al-
though an organ-specific pattern ofcontactibin variants
has been found, tumors express contactibin-forms that
are not organ restricted. The variants seem to arise
from altered glycosylation of contactibin.
By development of an aggregation assay, we were
able to show that contactibin binds specifically to pro-
teins ofadetergent extractofhumandiploidfibroblasts.
This binding was inhibited by the presence ofanti-con-
tactibin antibodies or of plasma membrane proteins.
Only marginal binding ofcontactibin has been observed
to plasma membrane proteins ofSV-40 transformed hu-
man fibroblasts, indicatingthat in transformed cells the
postulated receptor is defective or is no longer synthe-
sized. In addition to our findings, Peterson and Lerch
have shown that contact-dependent inhibition ofgrowth
can be restored in transformed cells by fusing plasma
membranes of nontransformed cells with their trans-
formed counterparts (25), giving evidence that the pri-
mary growth control defect in transformed cells resides
within the plasma membrane. The actual data do not
allow a clear answer to the question of whether the
receptorin transformed cells is defective oris no longer
synthesized, but the results of several studies point to
a defective state. It has been shown that normal cells
canbe phenotypically transformed byinhibitors ofphos-
photyrosine phosphatases (26). Furthermore, inhibitors
of cyclic phosphodiesterase lead to the appearance of
contact-dependent inhibition of growth in transformed
cells (27).
Conclusions
Sparsely seeded cells express contactibin in a higher
sialylated form than confluent cells. This could be a re-
flection of a cell-cycle specific synthesis of contactibin,
or could be due to a release of terminal sialic acids by
a membrane-bound sialidase upon establishment ofcell-
cell contacts.
Upon unmasking of terminal, ,-glycosidically linked
galactose residues, contactibin can bind to a specific
receptor. The receptoris suggested tobe highly specific
forthe sugarmoieties ofcontactibin, as onlythe glyeans
have biological activity and as other glycoproteins with
terminal ,B-glycosidicallylinkedgalactoseresidues(e.g.,
asialofetuin, alpha acid glycoprotein) have no effect on
growth.
Once a closed monolayer has developed, reinitiation
of proliferation is postulated to be possible only when
the cell-cell contacts formed by contactibin and the con-
tactibin receptor are broken. This may be due to the
action ofproteases, which are thought to be induced by
growth factors orby urea. The growth inhibitory signal
starting from the contactibin receptor is thought to be
triggered by phosphorylation reactions.
Transformation leadsto adefective receptormolecule
that is no longer able to bind to contactibin. Therefore,
growth inhibitory cell interactions are suppressed. The
defect may be due to altered phosphorylation or altered
and defective synthesis. Activationofcertainoncogenes
may lead to enhanced phosphorylation, perhaps pref-
erentially of the contactibin receptor, and thus enable
cells to escape the contact-dependent inhibition of
growth.
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